DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2257902/danaher-dhr-gears-up-to-post-q1-earnings-is-a-beat-likely?cid=CS-ZC-FT-analyst_blog|earnings_preview-2257902 Apr 18, 2024 - Danaher's (DHR) Q1 earnings are likely to be hurt by weakness in the Biotechnology unit. Improving supply chains and strong price realization are expected to be positives. 0

https://www.zacks.com/stock/news/2257699/carlisle-csl-earnings-expected-to-grow-what-to-know-ahead-of-next-week-s-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2257699 Apr 18, 2024 - Carlisle (CSL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 0

https://www.zacks.com/stock/news/2257937/will-danaher-dhr-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2257937 Apr 18, 2024 - Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. 0

https://www.zacks.com/stock/news/2259366/honeywell-hon-to-report-q1-earnings-is-a-beat-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2259366 Apr 22, 2024 - Honeywell's (HON) first-quarter results are likely to have benefited from strength across most of its businesses. Weakness in the warehouse automation market might have been a spoilsport. 0

https://www.zacks.com/commentary/2261192/top-stock-reports-for-danaher-regeneron-pharmaceuticals-palo-alto-networks?cid=CS-ZC-FT-research_daily-2261192 Apr 24, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Danaher Corporation (DHR), Regeneron Pharmaceuticals, Inc. (REGN) and Palo Alto Networks, Inc. (PANW). 0

https://www.zacks.com/stock/news/2194747/danaher-dhr-acquires-abcam-to-boost-life-sciences-segment?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2194747 Dec 07, 2023 - Danaher (DHR) acquires Abcam for $5.7 billion, thus adding to its Life Sciences portfolio. This move will facilitate the mapping of complex diseases and expedite the drug discovery process. 0

https://www.zacks.com/stock/news/2208554/danaher-dhr-stock-declines-while-market-improves-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2208554 Jan 10, 2024 - Danaher (DHR) closed the most recent trading day at $229.64, moving -0.53% from the previous trading session. 0

https://www.zacks.com/stock/news/2212826/3m-mmm-gears-up-to-post-q4-earnings-is-a-beat-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2212826 Jan 19, 2024 - 3M's (MMM) fourth-quarter 2023 results are likely to have gained from strength across its automotive OEM and medical solutions businesses. However, weak commercial solutions and transportation safety markets might have hurt its results. 0

https://www.zacks.com/stock/news/2213135/can-general-electric-ge-q4-earnings-beat-on-aerospace-boost?cid=CS-ZC-FT-analyst_blog|earnings_preview-2213135 Jan 19, 2024 - Strength in the Aerospace segment and accretive acquisitions are likely to aid General Electric's (GE) fourth-quarter 2023 results. 0

https://www.zacks.com/stock/news/2214255/danaher-dhr-expected-to-beat-earnings-estimates-can-the-stock-move-higher?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2214255 Jan 23, 2024 - Danaher (DHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 0